Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only

PHASE3CompletedINTERVENTIONAL
Enrollment

703

Participants

Timeline

Start Date

September 20, 2016

Primary Completion Date

October 30, 2017

Study Completion Date

December 8, 2017

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

semaglutide

Oral administration once daily.

DRUG

placebo

Oral administration once daily.

Trial Locations (105)

1233

Novo Nordisk Investigational Site, Sofia

1431

Novo Nordisk Investigational Site, Sofia

11000

Novo Nordisk Investigational Site, Belgrade

11215

Novo Nordisk Investigational Site, Brooklyn

11694

Novo Nordisk Investigational Site, Prague

14224

Novo Nordisk Investigational Site, West Seneca

16000

Novo Nordisk Investigational Site, Algiers

16003

Novo Nordisk Investigational Site, Algiers

16049

Novo Nordisk Investigational Site, Algiers

19140

Novo Nordisk Investigational Site, Philadelphia

20230

Novo Nordisk Investigational Site, Aguascalientes

20782

Novo Nordisk Investigational Site, Hyattsville

22042

Novo Nordisk Investigational Site, Como

23219

Novo Nordisk Investigational Site, Richmond

27203

Novo Nordisk Investigational Site, Asheboro

27408

Novo Nordisk Investigational Site, Greensboro

28277

Novo Nordisk Investigational Site, Charlotte

29303

Novo Nordisk Investigational Site, Spartanburg

33012

Novo Nordisk Investigational Site, Hialeah

33026

Novo Nordisk Investigational Site, Pembroke Pines

33143

Novo Nordisk Investigational Site, Miami

33166

Novo Nordisk Investigational Site, Doral

33173

Novo Nordisk Investigational Site, Miami

33186

Novo Nordisk Investigational Site, Miami

33607

Novo Nordisk Investigational Site, Tampa

33952

Novo Nordisk Investigational Site, Port Charlotte

34096

Novo Nordisk Investigational Site, Istanbul

34147

Novo Nordisk Investigational Site, Istanbul

34303

Novo Nordisk Investigational Site, Istanbul

34371

Novo Nordisk Investigational Site, Istanbul

34400

Novo Nordisk Investigational Site, Istanbul

34609

Novo Nordisk Investigational Site, Spring Hill

34718

Novo Nordisk Investigational Site, Istanbul

34722

Novo Nordisk Investigational Site, Istanbul

34752

Novo Nordisk Investigational Site, Istanbul

40213

Novo Nordisk Investigational Site, Louisville

44094

Novo Nordisk Investigational Site, Willoughby Hills

45255

Novo Nordisk Investigational Site, Cincinnati

47304

Novo Nordisk Investigational Site, Muncie

48098

Novo Nordisk Investigational Site, Troy

48307

Novo Nordisk Investigational Site, Rochester

49009

Novo Nordisk Investigational Site, Kalamazoo

53100

Novo Nordisk Investigational Site, Siena

56124

Novo Nordisk Investigational Site, Pisa

58104

Novo Nordisk Investigational Site, Fargo

60077

Novo Nordisk Investigational Site, Skokie

68022

Novo Nordisk Investigational Site, Elkhorn

70002

Novo Nordisk Investigational Site, Metairie

73069

Novo Nordisk Investigational Site, Norman

73112

Novo Nordisk Investigational Site, Oklahoma City

75149

Novo Nordisk Investigational Site, Mesquite

75230

Novo Nordisk Investigational Site, Dallas

76710

Novo Nordisk Investigational Site, Waco

77058

Novo Nordisk Investigational Site, Houston

77479

Novo Nordisk Investigational Site, Sugar Land

77900

Novo Nordisk Investigational Site, Olomouc

78215

Novo Nordisk Investigational Site, San Antonio

78224

Novo Nordisk Investigational Site, San Antonio

78230

Novo Nordisk Investigational Site, San Antonio

83221

Novo Nordisk Investigational Site, Blackfoot

84010

Novo Nordisk Investigational Site, Bountiful

89440

Novo Nordisk Investigational Site, Ciudad Madero

90057

Novo Nordisk Investigational Site, Los Angeles

90129

Novo Nordisk Investigational Site, Palermo

91606

Novo Nordisk Investigational Site, North Hollywood

91763

Novo Nordisk Investigational Site, Montclair

92111

Novo Nordisk Investigational Site, San Diego

92506

Novo Nordisk Investigational Site, Riverside

93534

Novo Nordisk Investigational Site, Lancaster

94401

Novo Nordisk Investigational Site, San Mateo

95148

Novo Nordisk Investigational Site, San Jose

96814

Novo Nordisk Investigational Site, Honolulu

100018

Novo Nordisk Investigational Site, Ploieşti

130086

Novo Nordisk Investigational Site, Târgovişte

130095

Novo Nordisk Investigational Site, Târgovişte

140091

Novo Nordisk Investigational Site, Dzerzhinskiy

150003

Novo Nordisk Investigational Site, Yaroslavl

194358

Novo Nordisk Investigational Site, Saint Petersburg

199226

Novo Nordisk Investigational Site, Saint Petersburg

394018

Novo Nordisk Investigational Site, Voronezh

420073

Novo Nordisk Investigational Site, Kazan'

424004

Novo Nordisk Investigational Site, Yoshkar-Ola

630099

Novo Nordisk Investigational Site, Novosibirsk

634050

Novo Nordisk Investigational Site, Tomsk

34684-3609

Novo Nordisk Investigational Site, Palm Harbor

30189-4255

Novo Nordisk Investigational Site, Woodstock

83686-6011

Novo Nordisk Investigational Site, Nampa

78228-3419

Novo Nordisk Investigational Site, San Antonio

23510-2015

Novo Nordisk Investigational Site, Norfolk

24153-6404

Novo Nordisk Investigational Site, Salem

Unknown

Novo Nordisk Investigational Site, Algiers

Novo Nordisk Investigational Site, Istanbul

550 01

Novo Nordisk Investigational Site, Broumov

537 01

Novo Nordisk Investigational Site, Chrudim

293 50

Novo Nordisk Investigational Site, Mladá Boleslav

00168

Novo Nordisk Investigational Site, Rome

565-0853

Novo Nordisk Investigational Site, Suita-shi, Osaka

103-0027

Novo Nordisk Investigational Site, Tokyo

103-0028

Novo Nordisk Investigational Site, Tokyo

104-0031

Novo Nordisk Investigational Site, Tokyo

160-0008

Novo Nordisk Investigational Site, Tokyo

236-0004

Novo Nordisk Investigational Site, Yokohama-shi, Kanagawa

010825

Novo Nordisk Investigational Site, Bucharest

011234

Novo Nordisk Investigational Site, Bucharest

01250

Novo Nordisk Investigational Site, Adana

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT02906930 - Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only | Biotech Hunter | Biotech Hunter